Lithium Level Monitoring After Initiation
Check serum lithium levels twice per week during the acute phase until both the serum concentration and clinical condition have stabilized. 1
Initial Monitoring Schedule
The FDA-approved labeling provides clear guidance for lithium monitoring after initiation:
- During acute phase: Measure serum lithium levels twice weekly until stabilization occurs 1
- Timing of blood draw: Collect samples 8-12 hours after the previous dose (immediately before the next dose) when concentrations are relatively stable 1
- Target therapeutic range during acute mania: 1.0-1.5 mEq/L 1
Critical Timing Considerations
For once-daily dosing regimens, the standard 12-hour sampling protocol does not apply:
- Serum levels should be drawn at 24 hours post-dose (not 12 hours) for patients taking sustained-release lithium once daily 2
- The 12-hour level can be 1.3 times higher than the actual trough level at 24 hours, potentially leading to underdosing if used as the reference point 2
Factors Requiring Earlier or More Frequent Monitoring
Several clinical situations necessitate more vigilant monitoring:
- Concurrent medications: NSAIDs and diuretics that interact with lithium require earlier and more frequent checks 3
- Renal function: Baseline renal function must be established before starting lithium, and any decline warrants immediate reassessment 3
- Symptoms of toxicity: Any signs of toxicity mandate immediate level checking regardless of the scheduled monitoring interval 3
Common Pitfalls to Avoid
- Failing to establish baseline renal function before initiating therapy is a critical error that can lead to toxicity 3
- Relying solely on serum levels: The FDA label explicitly states that "total reliance must not be placed on serum levels alone" - accurate evaluation requires both clinical and laboratory analysis 1
- Incorrect timing of blood draws: Drawing levels at the wrong time relative to dosing can result in misleading values and inappropriate dose adjustments 1, 2
- Overlooking intercurrent illness: Lithium should be temporarily suspended during illness, IV radiocontrast administration, bowel preparation, or prior to major surgery to prevent toxicity 3
Transition to Maintenance Monitoring
Once stabilized on lithium: